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Abstract
Background: Fetal immune responses following exposure of mothers to allergens during pregnancy may influence
the subsequent risk of childhood asthma. However, the association of allergen-induced cord blood mononuclear
cell (CBMC) proliferation and cytokine production with later allergic immune responses and asthma has been
controversial. Our objective was to compare indoor allergen-induced CBMC with age 5 peripheral blood
mononuclear cell (PBMC) proliferation and determine which may be associated with age 5 allergic immune
responses and asthma in an inner city cohort.
Methods: As part of an ongoing cohort study of the Columbia Center for Children’s Environmental Health
(CCCEH), CBMCs and age 5 PBMCs were cultured with cockroach, mouse, and dust mite protein extracts. CBMC
proliferation and cytokine (IL-5 and IFN-g) responses, and age 5 PBMC proliferation responses, were compared to
anti-cockroach, anti-mouse, and anti-dust mite IgE levels, wheeze, cough, eczema and asthma.
Results: Correlations between CBMC and age 5 PBMC proliferation in response to cockroach, mouse, and dust
mite antigens were nonsignificant. Cockroach-, mouse-, and dust mite-induced CBMC proliferation and cytokine
responses were not associated with allergen-specific IgE at ages 2, 3, and 5, or with asthma and eczema at age 5.
However, after adjusting for potential confounders, age 5 cockroach-induced PBMC proliferation was associated
with anti-cockroach IgE, total IgE, and asthma (p < 0.05).
Conclusion: In contrast to allergen-induced CBMC proliferation, age 5 cockroach-induced PBMC proliferation was
associated with age 5 specific and total IgE, and asthma, in an inner-city cohort where cockroach allergens are
prevalent and exposure can be high.
Background
There has been longstanding controversy in the litera-
ture regarding whether biomarkers measured in cord
blood may help predict subsequent childhood asthma or
atopy [1-9]. Prospective birth cohorts studies have
demonstrated that cord blood IgE is a better predictor
of skin prick test (SPT) positivity to aeroallergens (dust
mite, grass, cat and dog) than family history when
assessed up to age 5 years [2,6,7]. A similar positive
association with early asthma at age 5 years has been
more difficult to demonstrate [2,7]. However, others
have shown a positive association between elevated cord
blood IgE with risk of later asthma at age 10 years [9],
and allergic rhinoconjunctivitis at age 20 years [8].
T h ef i n d i n g sc o n t i n u et ob em i x e dw h e nc o m p a r i n g
aeroallergen-induced cord blood mononuclear cell
(CBMC) proliferation with the subsequent risk for
developing asthma, eczema, and allergic rhinitis [10-12].
At birth, infants who developed allergic disease by age 1
year had significantly more positive CBMC responses to
d u s tm i t ea n df o o da l l e r g e nproteins than newborns
who did not develop allergy [13]. Notably, one birth
cohort that followed children as long as 6 years demon-
strated no significant difference in aeroallergen-induced
(dust mite, grass, mold, cat) CBMC proliferation among
cord blood samples of children who subsequently devel-
oped atopic disease by 6 years of age compared with
samples from children who did not [14]. It has been
argued that allergen-induced CBMC proliferation may
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emigrants as opposed to a more mature T cell memory
response [15]. However, other approaches, such as those
using MHC tetramer staining, have demonstrated anti-
gen specific intrauterine T cell immune response follow-
ing environmental exposures that display features of
immunologic effector memory [16].
Only a few studies have reported on mitogen or anti-
gen-induced CBMC T helper (Th) cytokine production,
and compared their levels with the likelihood of later
atopy. For example, increased phytohemagglutinin
(PHA)-induced interleukin (IL)-5 and IL-13 was asso-
ciated with increased total IgE during the first year of
life [17]. Dust mite-induced CBMC production of IL-13
was associated with SPT positivity in response to dust
mite antigens at age 6 [10]. However, associations
between dust mite-induced CBMC production of IL-6
and IL-10 and subsequent atopic disease (i.e. asthma,
eczema) or SPTs at age 6 years were absent [10,18].
Despite this body of work, studies to date have not yet
compared prospectively the association between anti-
gen-induced lymphoproliferative responses in cord
blood with repeat measures in later childhood, and
assessed the relative strengths of their associations with
childhood asthma or eczema. In addition, the roles of
early immune responses following ex vivo stimulation
with cockroach and mouse proteins, antigens associated
with inner city asthma [19,20], have not been fully eluci-
dated. Our objective, using a longitudinal birth cohort
designed to examine risk factors for the development of
asthma in an inner city population, was to compare
cockroach, mouse and dust mite antigen-induced lym-
phoproliferative response in cord blood with age 5 anti-
gen-specific lymphoproliferative response among the
same children, and determine whether either were asso-
ciated with a greater likelihood of age 5 atopy. We
hypothesized that indoor allergen-specific cord blood
proliferation and Th2 cytokine production would be
associated with subsequent childhood (ages 2, 3, and 5)
IgE, asthma, and eczema. We report that, in contrast to
allergen-induced CBMC proliferation, age 5 cockroach-
induced PBMC proliferation was associated with age 5
specific and total IgE, and asthma, in an inner-city
cohort where cockroach allergens are prevalent and
exposure can be high.
Methods
Study subjects
As part of an ongoing longitudinal birth cohort study
conducted under the auspices of the Columbia Center
for Children’s Environmental Health (CCCEH), women
ages 18 to 35, living in Northern Manhattan and the
South Bronx, were enrolled during pregnancy (n = 725)
from clinics affiliated with New York Presbyterian
Hospital (Columbia campus) or Harlem Hospital as
described [19,21,22]. Exclusion criteria for pregnant
women included smoking, illicit drug use, diabetes,
hypertension, HIV infection, and residence in New York
City for less than one year.
From this cohort of fully enrolled mothers, a sample
based on the number of children from whom a blood
sample was obtained (i.e. any time point from cord
blood through age 5 years) was selected for inclusion
(n = 609). For longitudinal analysis, a subset (n = 359)
inclusive of all children for whom cord blood was col-
lected and data were available for prospective analysis at
age 2, 3 and 5 year was studied. For cross-sectional ana-
lysis, another overlapping subset (n = 352) inclusive of
all children for whom age 5 blood was collected was
assessed for concurrent (age 5) outcomes symptoms.
Written informed consent was obtained from all study
participants and Columbia University’s Institutional
Review Board approved the study.
Questionnaires
Detailed questionnaires were administered to women
prenatally, every 3 months until the child was age 2, and
every 6 months thereafter until age 5 [19,22]. Question-
naires assessed demographics, maternal asthma, environ-
mental tobacco smoke (ETS) exposure, and report of
wheeze, cough and physician diagnosis of asthma and/or
eczema. Furthermore, at age 5, parental report of
eczema was determined using the validated International
S t u d yo fA s t h m aa n dA l l e r g yi nC h i l d h o o d( I S A A C )
eczema questionnaire [23-25], and parental report of
asthma was determined using the locally validated Brief
Respiratory Questionnaire (BRQ) [26].
Home allergen measurements
Dust samples were vacuumed separately from kitchens
and mothers’ beds prenatally and were analyzed for
mouse urinary protein (MUP), dust mite (Der f 1), and
cockroach (Bla g 2) allergens by enzyme-linked immu-
nosorbent assay (ELISA) as described [27-30].
Blood collection, mononuclear proliferation, cytokine
assays, and IgE
Cord bloods were collected at delivery and maternal
blood within 1 day postpartum [19,21,22,31]. Peripheral
blood samples at 2, 3 and 5 years of age were collected.
Briefly, fresh mononuclear cells were isolated by density
centrifugation and plated in triplicate for mononuclear
proliferation and in duplicate for cytokine assays. Anti-
gen-induced mononuclear cell proliferation and cytokine
production were measured in cord blood and in periph-
eral blood at age 5 years.
Mononuclear cells (3 × 10
5 cells/well) were cultured
in microtiter plates for 5 days with Blatella germanica
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Lenoir, NC), Dermatophagoides farinae (dust mite;
10 μg/ml; Greer Laboratories, Lenoir, NC), Mus muscu-
lus (mouse protein extract; 10 μg/ml; Greer Labora-
tories, Lenoir, NC), or no antigen [21]. Increased
proliferation in response to German cockroach, dust
mite, and mouse protein extract antigens were detected
by tritiated thymidine incorporation. Increased mono-
nuclear cell proliferation were defined as (1) a stimula-
tion index [SI] (averaged counts per minute [cpm] in
the presence of antigen divided by averaged cpm with-
out antigen) greater than 2, and (2) antigen-induced
cpm greater than 1,000 above background [21]. Separate
cell aliquots for cytokine analysis were cultured under
identical conditions, and supernatants were collected at
day 5 and analyzed in duplicates for IL-5 and IFN-g via
ELISA kits (Immunotech, Marseille, France) [21].
Anti-cockroach, anti-mouse, and anti-dust mite IgE
levels were measured in sera initially by using the Fluor-
escence Allergosorbent Test (FAST) (Bio Whittaker,
Walkersville, MD) until August 2002. Subsequently, all
samples were measured by ImmunoCAP (Phadia,
Uppsala, Sweden). Total IgE levels were measured initi-
ally by immunoradiometric assay (IRMA) (Total IgE
IRMA; Diagnostics Products Corp, Los Angeles, CA),
and subsequently (after August 2002) by ImmunoCAP
(Phadia, Uppsala, Sweden). All samples were measured
in duplicate and during the transition of one validated
method to another, a subset was analyzed using both
methods to ensure correlation of results, as previously
described [19]. Antigen-specific IgE levels of 0.35 IU/ml
or greater (class I) were considered positive.
Statistical analyses
Data were analyzed with SPSS version 16.0 (SPSS, Inc,
Chicago, Ill). Dust allergens levels were analyzed as nat-
ural logarithm-transformed continuous values and in
tertiles. Mononuclear cell proliferation results were ana-
lyzed as continuous (antigen-induced cpm divided by
background cpm) or dichotomous (positive versus nega-
tive SI) variables. Cytokine responses to cockroach,
mouse, and dust mite antigens were measured as cyto-
kine ratios: (measured response to antigen)/(measured
response to background condition) and analyzed as con-
tinuous variables. Allergen-specific IgE levels were ana-
lyzed as dichotomous variables (≥0.35 IU/ml, <0.35 IU/
ml). Total IgE and sum of allergen-specific IgE (sum of
anti-cockroach, anti-mouse, and anti-dust mite IgE)
were analyzed as continuous variables. The later
approach was intended to study a derived indicator of
allergic sensitization to indoor allergens, important to
inner city asthma [19], with the benefit of greater statis-
tical power. All values below limit of detection (LOD)
were recoded as half LOD. Symptoms and diagnoses
assessed by questionnaires were analyzed as dichoto-
mous variables (yes or no). All continuous variables
were natural log transformed.
Fisher’s Exact Test and nonparametric tests, including
Mann-Whitney U (MWU) Test, Kruskal-Wallis Test,
and Spearman’s rho correlation, were used to ensure
data results were not distorted by failure to fulfill para-
metric distribution requirements. Unadjusted logistic
and linear regression analyses were performed to assess
whether allergen-specific mononuclear cell proliferation
were significant predictors of atopy and asthma, eczema,
allergen-specific IgE levels, and total IgE levels. Adjusted
multivariate logistic and linear regression models were
examined to adjust for (1) child’s sex, (2) ethnicity, (3)
any ETS exposure at home at age of interest, (4) mater-
nal history of asthma, and (5) prenatal allergen levels in
bed. Interaction terms also were examined between each
independent variables of interest and each of the five
covariates described above in order to differentiate
between confounders and effect modifiers. Statistical sig-
nificance was defined as a two-tailed p < 0.05.
Results
Study population, age-related indoor antigen-induced
proliferation
Children were predominantly Dominican (63.8%) with
lower socioeconomic status and frequent use of public
assistance. Twenty one percent of the mothers reported
asthma, whereas asthma diagnosis in the child ranged
from approximately 15% to 17.7% at ages 2, 3 respec-
tively, and occurred among 29.6% by age 5 years (Tables
1, 2).
Table 1 Characteristics of Study Children
% n/Total
Sex
Female 52.0 316/608
Ethnicity
Dominican 63.8 388/608
African American 36.2 220/608
Maternal History of Asthma 21.4 130/608
Prenatal ETS Exposure* 49.7 237/477
Postnatal ETS Exposure
Age 2 43.5 202/464
Age 3 49.3 225/456
Age 5 59.2 239/404
Maternal Highest Degree
High School Diploma or More 64.9 389/599
Currently on Medicaid 90.3 548/607
Currently in Public Assistance 42.3 255/603
Values shown are validated percents to account for missing variables.
ETS, environmental tobacco smoke
*In the absence of maternal smoking
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PBMC proliferation in response to all three antigens
examined were absent even after stratifying by antigen-
specific maternal blood proliferation positivity (Table 3).
In addition, maternal and cord blood mononuclear cell
proliferation continued to differ with each other in
response to cockroach as reported in 2001 [21] and now
when reanalyzed in 2010 (2001: n = 133, p < 0.05 by
Fisher’s Exact Test; 2010: n = 277, p < 0.05 by Fisher’s
Exact Test). However, statistically differences between
maternal and cord blood in the response to mouse anti-
gen that were absent in 2001 were now detected in the
larger data set (2001: n = 132, p > 0.05 by Fisher’s Exact
Test; 2010: n = 252, p < 0.05 by Fisher’sE x a c tT e s t ) .I n
comparison, statistically significant maternal versus cord
blood differences follow exposure to dust mite antigens
detected in 2001 were not apparent in 2010 with the
larger data set (2001: n = 131, p < 0.05 by Fisher’s Exact
Test; 2010: n = 259, p > 0.05 by Fisher’s Exact Test)
[21]. Furthermore, antigen-specific maternal blood
mononuclear cell proliferation was not correlated with
antigen-specific age 5 mononuclear cell proliferation
(cockroach antigen n = 87, p = 0.82; mouse antigen
n = 75, p = 0.33; dust mite antigen n = 80, p = 0.07l; by
Fisher’s Exact Test), suggesting that maternal antigen-
induced peripheral blood mononuclear cell proliferation
does not predict the development of specific antigen-
induced T cell proliferative responses in their children
through age 5 years.
Cord blood proliferation, cytokine production, IgE and
respiratory symptoms
By age 5 years, 18.8%, 10.8%, and 8.1% of children devel-
oped positive anti-cockroach, anti-mouse, and anti-dust
mite IgE, respectively (Figure 1). However, cockroach-,
mouse-, and dust mite-induced CBMC proliferation and
IL-5 and IFN-g cytokine production were not associated
with antigen-specific or total IgE levels at ages 2, 3, or 5
(data not shown), suggesting that antigen-induced T cell
allergic immune responses in CBMC are not associated
with a greater likelihood of developing allergen-specific
IgE responses in early childhood. To assess prospectively
whether antigen-induced T cell proliferative responses
were associated with asthma and eczema symptoms
through age 5 years, CBMC proliferation was compared
to the frequency of parental report of asthma, cough
without a cold, wheeze and eczema. Antigen-specific
CBMC proliferation was not associated with maternal
report of child asthma, cough, wheeze or eczema at ages
2, 3, and 5 (p > 0.05).
Table 2 Childhood Symptoms at Ages 2, 3, and 5 Years
Frequency (%) n/Total
Age 2
Asthma
1 15.2 41/269
Wheeze
1 15.3 41/268
Cough
1 50.2 135/269
Eczema
1 21.6 57/264
Age 3
Asthma
1 17.7 48/274
Wheeze
1 11.8 32/272
Cough
1 47.1 128/272
Eczema
1 25.1 68/271
Age 5
Physician Diagnosed Asthma
2 29.6 66/223
Wheeze/Whistling/Cough/Other
2 31.8 71/223
Cough
1 49.2 119/242
Itchy Rash Last 12 months
3 65.9 29/44
Ever Had Eczema
3 27.9 62/222
Values shown are validated percents to account for missing variables.
Sample inclusive of children in whom we have cord blood biological data (n
= 359).
Parental report of symptoms assessed by:
1Study Questionnaire,
2Brief
Respiratory
Questionnaire, and
3ISAAC Eczema Module.
ISAAC, International Study of Asthma and Allergy in Childhood
Table 3 Correlation of Cord Blood and Age 5 Blood
Antigen Specific Proliferation
Cord Blood
N R *p-value
Age 5 Blood Cockroach 97 -0.033 0.750
Mouse 86 -0.074 0.5
Dust Mite 88 -0.171 0.111
Analyses by Spearman’s rho correlations, p-value two-tailed
N, number of observations
R, correlation coefficient
*Results did not differ after stratifying by antigen-specific maternal blood
proliferation positivity.
Anti-Dust Mite Anti-Mouse Anti-Cockroach
*
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Figure 1 Frequency (%) of Antigen-Specific IgE Positivity at
Ages 2, 3, and 5. *Anti-cockroach, anti-mouse, anti-dust mite IgE
positivity is defined as ≥ 0.35 IU/ml.
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To ascertain whether concurrent antigen-induced PBMC
proliferation is associated with IgE outcomes at age 5
years, cross-sectional comparisons between age 5 year
PBMC proliferation and total and allergen-specific IgE
levels were conducted. In univariate analysis, cockroach
antigen-induced PBMC proliferation was not associated
with anti-cockroach IgE production (n = 113, OR 1.75,
95% CI 0.69, 4.42) (Table 4). However, after adjusting
for potential confounders (sex, ethnicity, current ETS
exposure, maternal asthma, prenatal cockroach allergen
levels in bed), children with positive cockroach-induced
PBMC proliferation had almost 3.4 times increased odds
of positive concurrent anti-cockroach IgE (n = 78, OR
3.39, 95% CI 1.05, 10.92) compared to children without
positive cockroach-induced PBMC proliferation (Table
4). In addition, significant interactions were detectable
between age 5 cockroach-induced PBMC proliferation
w i t he t h n i c i t y( p=0 . 0 4 )a n ds e x( p=0 . 0 1 )o na g e5
anti-cockroach IgE. In stratified adjusted models, the
associations between cockroach-induced PBMC prolif-
eration and anti-cockroach IgE at age 5 years was
detected amongst African Americans (b = 1.86, p =
0.00) and girls (b = 1.05, p = 0.00).
Moreover, cockroach antigen-induced PBMC prolif-
eration was correlated weakly with total IgE production
at age 5 (n = 120, Spearman’s rho r = 0.225, p = 0.01).
Cockroach antigen-induced PBMC proliferation was
associated significantly with total IgE levels, after adjust-
ing for potential confounders (n = 85, b = 1.05, p =
0.00) (Table 4). In contrast, mouse- and dust mite-
induced PBMC proliferation did not demonstrate signifi-
cant associations with antigen-specific IgE or total IgE at
age 5 years (MWU Test p > 0.05). Cockroach and
mouse allergen levels in bed and kitchen were not
associated with antigen-specific CBMC or age 5 PBMC
proliferation ratios (Kruskal-Wallis Test p > 0.05).
Positive cockroach-induced age 5 PBMC proliferation
also was associated significantly with the report of physi-
cian-diagnosed asthma at age 5 (n = 131, MWU Test
p = 0.03). This finding was confirmed after adjusting for
the same potential confounders; age 5 children with
positive cockroach-induced PBMC proliferation had
three times increased odds of reported physician-diag-
nosed asthma at age 5 (n = 99, OR 3.08, 95% CI 1.13 to
8.37) compared to age 5 children without increased
cockroach-induced PBMC proliferation (Table 5).
In light of research indicating that the development of
eczema may be related to antigen-specific T cell immune
responses [14], further cross-sectional comparisons
between age 5 PBMC proliferation and prevalence of
reported eczema were conducted. In univariate analysis,
cockroach antigen-induced PBMC proliferation was asso-
ciated with eczema at age 5 years (n = 141, OR 2.41, 95%
CI 1.11, 5.22), but this association did not persist after
adjusting for potential confounders (sex, ethnicity, cur-
rent ETS exposure, maternal asthma, prenatal cockroach
allergen levels in bed) (Table 5). Mouse- and dust mite-
induced PBMC proliferation also were not associated
with asthma or eczema at age 5. Moreover, concurrent
cockroach-, mouse-, and dust mite-induced PBMC pro-
liferation was not associated with cough or wheeze at age
5 (MWU Test p > 0.05 for both).
Finally, anti-cockroach, anti-mouse, but not anti-dust
mite, IgE was associated significantly with concurrent
asthma and wheeze at age 5 years (Asthma n = 281-283:
anti-cockroach IgE, p = 0.00; anti-mouse IgE, p = 0.01;
anti-dust mite IgE, p = 0.54; Wheeze n = 280-282:
anti-cockroach IgE, p = 0.00; anti-mouse IgE, p = 0.00;
anti-dust mite IgE, p = 0.12 by MWU Test).
Table 4 Age 5 Cockroach Antigen-Induced PBMC Proliferation and IgE at Age 5 years
Outcomes
Anti-cockroach IgE ≥ 0.35 IU/ml Total IgE (IU/ml)
Predictors Crude OR
(95% CI)
[n = 113]
Adjusted OR
(95% CI)
[n = 78]
Crude b
[n = 124]
Adjusted b
[n = 85]
Positive cockroach-induced PBMC proliferation 1.75 (0.69, 4.42) 3.39 (1.05, 10.92) 0.63 (p = 0.02) 1.05 (p = 0.00)
Female sex NA 0.64 (0.22, 1.87) NA -0.80 (p = 0.02)
African American ethnicity
(Reference = Dominican)
NA 01.12 (0.36, 3.46) NA 0.30 (p = 0.37)
Age 5 ETS exposed NA 0.83 (0.27, 2.53) NA -0.22 (p = 0.51)
Maternal history of asthma NA 1.20 (0.38, 3.77) NA 0.31 (p = 0.39)
Prenatal cockroach allergen in bed (μg/g dust) NA 0.71 (0.46, 1.12) NA -0.10 (p = 0.36)
Results were based on univariate and multivariate, logistic and linear regression models. The endpoint anti-cockroach IgE is shown as odds ratio, and total IgE as
regression coefficients with two-tailed p-values. Interaction terms each examined in a separate model [data not shown] demonstrated significant interactions
between age 5 cockroach-induced PBMC proliferation with ethnicity (p = 0.04) and sex (p = 0.01) on age 5 anti-cockroach IgE. In stratified adjusted models, there
were significant positive associations between age 5 cockroach-induced PBMC proliferation and age 5 anti-cockroach IgE amongst African Americans (b = 1.86,
p = 0.00) and girls (b = 1.05, p = 0.00). Maternal asthma was defined as positive at either prenatal or 3-months postnatal time points. Cockroach prenatal
allergen levels (μg/g of dust) are expressed as natural log-transformed values. OR, odds ratio. ETS, environmental tobacco smoke. NA, not applicable.
Chang et al. Clinical and Molecular Allergy 2010, 8:11
http://www.clinicalmolecularallergy.com/content/8/1/11
Page 5 of 8Discussion
The major objective of this study was to compare cord
blood and age 5 year biomarkers such as indoor anti-
gen-specific proliferation and cytokine production and
determine whether either was associated with IgE and
symptoms related to atopy and asthma in an inner city
prospective cohort. We found that significant associa-
tions between antigen-specific cord blood and age 5
proliferation measures were absent. Instead, cockroach-
specific proliferation assessed concurrently at age 5
years, but not in cord blood, was associated with asthma
and IgE. Our focus on repeat measures and longitudinal
assessment of indoor allergen responses important to
inner city asthma [19,21,22] is novel.
A possible explanation for the association of age 5, but
not cord blood, cockroach antigen-induced mononuclear
cell proliferation with concurrent asthma and atopy may
be that cord blood immune responses at birth are less
mature or efficient. In support of this possibility is evi-
dence of reduced CBMC proliferation and Th cytokine
responses compared to adult responses after ex vivo sti-
mulation with allergens, PHA, lipid A, and peptidogly-
can [32,33]. Furthermore, there is evidence of impaired
function of T regulatory cells as well as reduced expres-
sion and immature phenotype of transcription factor
Foxp3, in cord blood compared to adults [32,34]. Also,
T cell epitope mapping demonstrated that in response
to allergen, CBMCs lack the fine specificity demon-
strated by adult cells [35]. Moreover, Woodfolk et al.
demonstrated evidence of differing strengths of T cell
proliferative responses to Trichophyton rubrum, related
to changes in T cell epitope recognition of the immuno-
dominant amino-terminal that occurred over the first
2 years of life, with no change in the peptide recognition
pattern after age 20 months [36]. However, it is becom-
ing evident from our work [16] and others’ [37] that the
fetal adaptive immune system can be highly functional
and capable of responding to antigens. Hence, an alter-
nate explanation for the association of antigen-specific
age 5 PBMC, but not CBMC, proliferation response
with age 5 atopic status is that even though initial T cell
priming to aeroallergens occurs across the placenta [38],
clinically significant allergic sensitization to inhalant
allergens occurs postnatally in early childhood [39].
Cord blood T cell responses may be specific and func-
tional, but not necessarily committed [11].
The finding that cockroach allergen-induced prolif-
eration at age 5 years is associated with IgE and
asthma-related symptoms, as opposed to responses to
other indoor allergens, is consistent with substantial
research indicating that cockroach allergen is impor-
tant in the pathogenesis of inner city asthma [40,41].
They also are consistent with evidence that allergen
levels in home dust can be associated with allergen-
induced proliferation [42]. Our additional finding that
anti-cockroach IgE at age 5 years is associated both
with asthma and eczema lends further support to the
observed association between cockroach allergen expo-
sure, specific allergic immune responses, and risk for
asthma and atopy. Importantly, there are regional dif-
ferences, as demonstrated by Matsui et al., regarding
the burden of household mouse allergens on inner-city
childhood asthma in Baltimore, Maryland [20]. Simi-
larly, the association between indoor allergen-specific
IgE and asthma and eczema was more apparent for
dust mite in other cohorts, where dust mites thrive
better, in comparison to New York City [43,44].
Further, the absence of an association between any
indoor antigen-induced proliferation and eczema sug-
gests that indoor allergen-induced T cell proliferative
responses, in contrast to B cell induced responses, may
not modulate the risk of developing eczema in an
inner city cohort [19]. Notably, significant positive
associations between age 5 cockroach-induced PBMC
Table 5 Cockroach Antigen-Induced PBMC Proliferation and Asthma, Eczema at Age 5 Years
Outcomes
Predictors Asthma
1
[n = 99]
OR (95% CI)
Eczema
2
[n = 93]
OR (95% CI)
Positive cockroach-induced PBMC proliferation 3.08 (1.13, 8.37) 2.09 (0.76, 5.75)
Female sex 0.35 (0.13, 0.92) 1.26 (0.47, 3.37)
African American ethnicity
(Reference = Dominican)
2.13 (0.81, 5.63) 1.28 (0.48, 3.40)
Age 5 ETS exposed 1.36 (0.51, 3.61) 1.93 (0.69, 5.40)
Maternal history of asthma 3.97 (1.43, 11.02) 3.48 (1.27, 9.56)
Prenatal cockroach allergen in bed (μg/g dust) 0.89 (0.62, 1.27) 0.99 (0.70, 1.39)
Results were based on multivariate logistic regression models. Maternal asthma was defined as positive at either prenatal or 3-months postnatal time points.
Cockroach prenatal allergen levels (μg/g of dust) are expressed as natural log-transformed values.
1BRQ,
2ISAAC Eczema Module
BRQ, Brief Respiratory Questionnaire.
ISAAC, International Study of Asthma and Allergy in Childhood.
ETS, environmental tobacco smoke
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but not boys may be a result of sex specific genetic lin-
kages as demonstrated by other groups [45,46]. None-
theless, given the wide array and repeated immune
responses to indoor antigens demonstrated by our
group and others [20,40-42], public health interventions
directed toward region-specific allergen reduction in the
home may have health benefits to all inner-city children.
We acknowledge several limitations to this study. Ato-
pic and respiratory symptom assessments were con-
ducted via standardized questionnaires based upon
maternal reporting. Parental report of physician diagno-
sis of asthma may not be standardized [26], potentially
resulting in misclassification. Due to insufficient sample
size, we were unable to compare antigen-specific CBMC
and age 5 year cytokine responses with clinical out-
comes. Furthermore, due to budgetary constraints, we
were not able to measure IgE isotype class switching
Th2 cytokines IL-4 and IL-13 and their association with
IgE levels. In addition, due to repeated analyses, signifi-
cant statistical interactions in regression models may
represent type 1 error. Despite the prospective longitu-
dinal design of the cohort, due to loss to follow-up,
many data analyses were cross-sectional. Finally, host
characteristics (i.e. genetics) may add to variations in
the results as the development of atopy is influenced by
genetic, developmental, and environmental factors
[47-49].
Conclusions
In conclusion, in contrast to cord blood, age 5 PBMC
cockroach antigen-induced proliferation was associated
with anti-cockroach and total IgE production and
asthma in an inner-city cohort where cockroach is a
prevalent allergen. If corroborated by further studies,
this finding lends to potential clinical significance for
use of antigen-specific proliferation assays as a biomar-
ker for current, but not future, atopic status in early
childhood.
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